Compare

Lexaria Bioscience Corp. vs Polomar Health Services, Inc. vs Onconetix, Inc. vs Rallybio Corp

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearLexaria Bioscience Corp.
LEXX
Polomar Health Services, Inc.
PMHS
Onconetix, Inc.
ONCO
Rallybio Corp
RLYB
Year ended2025-08-312025-12-312025-12-312025-12-31
Revenue$705.9K$648.2K$815.4K$858.0K
Revenue growth (YoY)+52.0%n/m-67.7%+34.9%
Gross margin99.6%71.0%77.6%n/a
Operating marginn/mn/mn/mn/m
Net marginn/mn/mn/mn/m
Net income-$11.90M-$10.70M-$14.03M-$8.98M
EPS (Diluted)-$0.66-$0.39-$16.56-$1.59
Operating cash flow-$10.45M-$396.0K-$9.68M-$29.81M
Free cash flow-$10.48Mn/an/an/a
Cash & equivalentsn/a$132.2Kn/a$31.37M
Total assets$4.18M$390.0K$24.93M$62.26M
Total liabilities$1.57M$1.61M$9.16M$4.30M
Shareholders' equity$2.99M-$1.22M$15.76M$57.96M
Return on year-end equity-398.1%n/a-89.0%-15.5%
Shares outstanding19.56M28.02M1.56M5.28M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearLexaria Bioscience Corp.Polomar Health Services, Inc.Onconetix, Inc.Rallybio Corp
Latest$705.9K
Ended 2025-08-31
$648.2K
Ended 2025-12-31
$815.4K
Ended 2025-12-31
$858.0K
Ended 2025-12-31
1 year earlier$464.3K
Ended 2024-08-31
$58.8K
Ended 2024-12-31
$2.52M
Ended 2024-12-31
$636.0K
Ended 2024-12-31
2 years earlier$226.2K
Ended 2023-08-31
$41.8K
Ended 2023-12-31
$58.5K
Ended 2023-12-31
n/a
3 years earlier$255.4K
Ended 2022-08-31
$34.5K
Ended 2022-12-31
n/an/a
4 years earlier$722.7K
Ended 2021-08-31
n/an/an/a